522 related articles for article (PubMed ID: 20501944)
21. ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung.
Nobre AR; Dalla E; Yang J; Huang X; Wullkopf L; Risson E; Razghandi P; Anton ML; Zheng W; Seoane JA; Curtis C; Kenigsberg E; Wang J; Aguirre-Ghiso JA
Nat Cancer; 2022 Oct; 3(10):1165-1180. PubMed ID: 36050483
[TBL] [Abstract][Full Text] [Related]
22. The Role of the Innate Immune System in Cancer Dormancy and Relapse.
Chernosky NM; Tamagno I
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830776
[TBL] [Abstract][Full Text] [Related]
23. Immunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view.
Senft D; Ronai ZA
Pigment Cell Melanoma Res; 2016 Jan; 29(1):27-42. PubMed ID: 26514653
[TBL] [Abstract][Full Text] [Related]
24. Metastatic dissemination of B16 melanoma: pattern and sequence of metastasis.
Alterman AL; Fornabaio DM; Stackpole CW
J Natl Cancer Inst; 1985 Oct; 75(4):691-702. PubMed ID: 3862901
[TBL] [Abstract][Full Text] [Related]
25. Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillance.
Landsberg J; Gaffal E; Cron M; Kohlmeyer J; Renn M; Tüting T
Pigment Cell Melanoma Res; 2010 Oct; 23(5):649-60. PubMed ID: 20649939
[TBL] [Abstract][Full Text] [Related]
26. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Iversen TZ
Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
[TBL] [Abstract][Full Text] [Related]
27. Breast Cancer Cell Re-Dissemination from Lung Metastases-A Mechanism for Enhancing Metastatic Burden.
Borriello L; Condeelis J; Entenberg D; Oktay MH
J Clin Med; 2021 May; 10(11):. PubMed ID: 34071839
[TBL] [Abstract][Full Text] [Related]
28. Statins attenuate outgrowth of breast cancer metastases.
Beckwitt CH; Clark AM; Ma B; Whaley D; Oltvai ZN; Wells A
Br J Cancer; 2018 Oct; 119(9):1094-1105. PubMed ID: 30401978
[TBL] [Abstract][Full Text] [Related]
29. Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma.
Tham M; Khoo K; Yeo KP; Kato M; Prevost-Blondel A; Angeli V; Abastado JP
Oncotarget; 2015 Sep; 6(26):22857-68. PubMed ID: 25762633
[TBL] [Abstract][Full Text] [Related]
30. Technical Advancements for Studying Immune Regulation of Disseminated Dormant Cancer Cells.
Ombrato L; Montagner M
Front Oncol; 2020; 10():594514. PubMed ID: 33251149
[TBL] [Abstract][Full Text] [Related]
31. The human T cell response to melanoma antigens.
Romero P; Cerottini JC; Speiser DE
Adv Immunol; 2006; 92():187-224. PubMed ID: 17145305
[TBL] [Abstract][Full Text] [Related]
32. Melanoma-Derived Soluble DC-HIL/GPNMB Promotes Metastasis by Excluding T-Lymphocytes from the Pre-Metastatic Niches.
Ramani V; Teshima T; Tamura K; Chung JS; Kobayashi M; Cruz PD; Ariizumi K
J Invest Dermatol; 2018 Nov; 138(11):2443-2451. PubMed ID: 29857071
[TBL] [Abstract][Full Text] [Related]
33. The Role of the ECM in Lung Cancer Dormancy and Outgrowth.
Parker AL; Cox TR
Front Oncol; 2020; 10():1766. PubMed ID: 33014869
[TBL] [Abstract][Full Text] [Related]
34. Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.
Yamshchikov G; Thompson L; Ross WG; Galavotti H; Aquila W; Deacon D; Caldwell J; Patterson JW; Hunt DF; Slingluff CL
Clin Cancer Res; 2001 Mar; 7(3 Suppl):909s-916s. PubMed ID: 11300491
[TBL] [Abstract][Full Text] [Related]
35. Metastatic melanoma cells escape from immunosurveillance through the novel mechanism of releasing nitric oxide to induce dysfunction of immunocytes.
Zhang XM; Xu Q
Melanoma Res; 2001 Dec; 11(6):559-67. PubMed ID: 11725202
[TBL] [Abstract][Full Text] [Related]
36. Innate and acquired immune surveillance in the postdissemination phase of metastasis.
Gonzalez H; Robles I; Werb Z
FEBS J; 2018 Feb; 285(4):654-664. PubMed ID: 29131550
[TBL] [Abstract][Full Text] [Related]
37. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
[TBL] [Abstract][Full Text] [Related]
38. Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model.
Piranlioglu R; Lee E; Ouzounova M; Bollag RJ; Vinyard AH; Arbab AS; Marasco D; Guzel M; Cowell JK; Thangaraju M; Chadli A; Hassan KA; Wicha MS; Celis E; Korkaya H
Nat Commun; 2019 Mar; 10(1):1430. PubMed ID: 30926774
[TBL] [Abstract][Full Text] [Related]
39. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency.
Cameron MD; Schmidt EE; Kerkvliet N; Nadkarni KV; Morris VL; Groom AC; Chambers AF; MacDonald IC
Cancer Res; 2000 May; 60(9):2541-6. PubMed ID: 10811137
[TBL] [Abstract][Full Text] [Related]
40. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
